Validity and Reliability of the 6-Minute Pegboard and Ring Test in Interstitial Lung Disease
NCT ID: NCT07122141
Last Updated: 2025-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
27 participants
OBSERVATIONAL
2025-04-25
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validity and Reliability of 6-minute Pegboard and Ring Test in Patients With Interstitial Lung Disease
NCT06948916
Evaluation of Novel Lung Function Parameters in Patients With Interstitial Lung Disease (ILD)
NCT02827734
Interstitial Lung Disease Questionnaire
NCT01711151
The relatıonshıp Between Upper Extremity Exercise Test and Exercise Capacity ın patıents wıth Idiopathic Pulmonary Fibrosis
NCT07119099
BAL Contribution to Lung Cryo-TBB in ILD
NCT07130110
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* were over 18 years of age,
* had not changed their treatment for the last 3 months,
* had a stable clinical status for the last 3 months.
Exclusion Criteria
* Orthopedic comorbidity that impairs upper extremity function,
* Kyphoscoliosis and/or severe postural abnormalities,
* Uncontrolled cardiac problems,
* Uncontrolled diagnosis of Diabetes Mellitus,
* Ischemic heart disease,
* Newly diagnosed history of cancer,
* Diagnosis of obstructive pulmonary disease,
* Cognitive impairments such as Alzheimer's or dementia,
* Use of immunosuppressive medications (excluding corticosteroids),
* History of recent surgery,
* Refusal to answer questions,
* Refusal to participate voluntarily.
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Marmara University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anıl Gökçen
Physiotherapist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anıl Gökçen, Phsiotheraphist
Role: PRINCIPAL_INVESTIGATOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Süreyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Upperextremity_ILD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.